‘They Need Each Other’: Why Hims & Hers and Novo Nordisk Made Up

Marissa Plescia / medcitynews - Novo Nordisk dropped its lawsuit against Hims & Hers and launched a new collaboration. The deal is advantageous for both companies, experts say.The post ‘They Need Each Other’: Why Hims & Hers and Novo Nordisk Made Up appeared first on MedCity News.

AI Summary: Novo Nordisk has dropped its legal fight with Hims & Hers and struck a business-friendly truce: Hims will sell Novo’s branded weight‑loss medications on its platform. The abrupt move turns courtroom theatrics into commercial collaboration, smoothing distribution while leaving regulators and competitors to enjoy the schadenfreude.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Amazon expands access to Ozempic pill with delivery and kiosks / 24 days

Novo Nordisk commits $2.1B to Vivtex to pursue oral obesity medicines / 2 months

Novo Nordisk legal action threat over copycat Wegovy pill / 3 months

Novo launches high‑dose Wegovy in US at $399 for self‑pay patients / 7 wks

Eli Lilly launches Employer Connect to broaden GLP‑1 coverage / 2 months

Lilly’s Zepbound bests Novo’s CagriSema in head‑to‑head obesity trial / 3 months

JP Morgan Healthcare Conference 2026: Pharma, AI, and Innovation Highlights / 4 months